Patent · US Expired

Polypeptide possessing thymic activity

US4133804A · kind A · utility

18Cited by
1References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 22, 1976
Grant dateJan 9, 1979
Priority date
Expiry dateSep 22, 1996

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/837
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The novel thymic factor polypeptide hormone, elaborated by the thymus and und in the blood serum, is isolated. The hormone is useful for the treatment of autoimmune diseases and for selectively stimulating T-cell activity in aging subjects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.